Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Long Term, Flexible Dose Study Of Safety, Tolerability, And Therapeutic Response In Patients With Parkinson's Disease.

NCT00036205 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00036205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Long Term, Flexible Dose Study Of Safety, Tolerability, And Therapeutic Response In Patients With Parkinson's Disease.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
August 31, 2000
Completion date
December 31, 2004
Enrollment
984
Sites
110

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease